🟡 60/100

Review before taking

  • Melatonin: 15mg is 1.5× the Tolerable Upper Intake Level (10mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Melatonin: 15mg is 1.5× the Tolerable Upper Intake Level (10mg)

The safety score is low because the 15mg dose of melatonin exceeds the recommended maximum daily limit of 10mg.

Label Data

1 Tablet(s) Serving Size
400 Servings
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

15 mg
⚠️ Exceeds Tolerable Upper Intake Level by 1.5× (UL: 10 mg) 📚 236 studies (Tier A: 2, B: 109)
This product: 15mg UL 10mg

Other Ingredients

Dicalcium Phosphate Croscarmellose Sodium Stearic Acid Microcrystalline Cellulose Magnesium Stearate Silicon Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 1 tablet 20 minutes before bedtime.

⚠️ Warnings & Precautions

For best results, please consult your physician.

Keep out of reach of children.

If pregnant/lactating or taking any medications, please consult your physician prior to use.

🧪 Formulation Notes

Vegan

Non-GMO No gluten

Free Of: Soy, dairy, yeast, gluten & additives.

Additional Information

Keep in a cool, dry place.

Product Details

UPC / SKU X0026DOFSX
DSLD Entry Date 2021-11-19
Product Type Non-Nutrient/Non-Botanical
Form Tablet or Pill
DSLD ID 256806
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →